Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer - Wikidata - awgldk - TriplyDB

Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer

Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer

http://www.wikidata.org/entity/Q36835186

about

Invariant NKT cells as novel targets for immunotherapy in solid tumors The role of NKT cells in tumor immunity NKT cell subsets as key participants in liver physiology and pathology Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions The functions of type I and type II natural killer T cells in inflammatory bowel diseases NKT cell networks in the regulation of tumor immunity The immunoregulatory role of type I and type II NKT cells in cancer and other diseases Cardiolipin Binds to CD1d and Stimulates CD1d-Restricted T Cells in the Normal Murine Repertoire Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor Invariant natural killer T cells and their ligands: focus on multiple sclerosis CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cells Natural lipid ligands associated with human CD1d targeted to different subcellular compartments Determination of cellular lipids bound to human CD1d molecules.Recognition of lyso-phospholipids by human natural killer T lymphocytes.Linking inflammation to natural killer T cell activation.Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.Stimulation of natural killer T cells by glycolipids Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Once again, rare diseases provide a spotlight.A novel self-lipid antigen targets human T cells against CD1c(+) leukemias Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid Secretion of IFN-gamma but not IL-17 by CD1d-restricted NKT cells enhances rejection of skin grafts expressing epithelial cell-derived antigen.NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease Natural killer T cells: innate lymphocytes positioned as a bridge between acute and chronic inflammation?Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.The split personality of NKT cells in malignancy, autoimmune and allergic disorders Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition.Recognition of CD1d-restricted antigens by natural killer T cells.Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.Identification of a Potent Microbial Lipid Antigen for Diverse NKT Cells.Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.Carbohydrate-containing molecules as potential biomarkers in colon cancer.

P2860

Q21284987-08994D9D-F802-4D0B-A8E5-0057A0042998 Q24648939-8BEC29D9-6D23-45E6-80DD-FEB4818108A5 Q26766141-A4483798-89B9-41EA-8E5D-63D7A925BC54 Q26768699-0F6B97E8-1364-40CA-B28F-DCA42C873159 Q26782520-7C984F4E-FEA7-490C-A645-EC9F7A579002 Q26797333-71C9F06D-FD04-4E17-BA22-81E5CE099C22 Q26797347-58D572B5-6C9E-4355-9FAB-63E5CC1FA2FD Q26865391-556AB5FD-AB1E-4003-91E1-47314C8E5BC9 Q26866223-5468CDE6-8244-49FF-A1A6-E4CADD6090CD Q27027556-2E5D2B07-189D-40BC-BEEE-F631E4E42416 Q27667243-1513059B-0D8C-4825-9B16-9AD1D4D53103 Q27681807-5D3B1174-52EE-4583-94CB-8FD8078D0C0F Q28083069-E63199E7-ED9E-4AB3-960D-ECA99102D757 Q30425388-627F15E3-57D5-47CC-BD67-2A7B83B53ED8 Q33426265-E2EE8A91-D198-44F8-9C08-0D6022D0101C Q33438880-4677AC15-BC3B-442A-A097-25694B4CF84B Q33512901-4948EBFA-AE84-47DD-9597-FD40F09A1B99 Q33512902-954011F1-D586-4778-9938-92B534A0861C Q33553298-61991551-D3B2-420E-B5C7-95CDCC7ED70D Q33599059-38AC5D56-CC90-4259-8F62-C47CC5304FA9 Q33724575-FDE750C5-590D-4219-9100-6DDDE950754B Q33731837-113293A9-8492-4422-B9A8-BE733155B2CE Q33826848-2488B3EF-AB14-445A-8B8B-E700118EA2D5 Q33934639-D78995C0-16C4-4A96-9411-B5400D5F2E13 Q34065735-6F6C0410-3714-4A96-B6E3-6C39E062D0D3 Q34288977-10216CCC-B28C-4952-B5C7-547D85A84AE4 Q34315871-109AAA35-DC47-40EE-823F-3D6B9145299E Q34364867-189DAB2F-C5F9-4CDA-BAF1-9F28A4B01A78 Q34388398-BB4B71DA-8F81-4A85-9D5E-A945015C24AF Q35103549-F4166E35-6FF9-4C3E-874B-FDF47A186FC2 Q35127172-AAFA71CC-B1B9-418A-A3BA-A80D60037710 Q35590727-807EDA5E-74D5-4D6F-9DBA-B23E17AE69A9 Q35750702-54852991-2500-44C6-AC8D-2476C94BE8F6 Q36719221-C5BDF9C3-74D0-4F24-A4EB-2950C4217723 Q36729593-48351070-B06B-42EC-83C4-2AC867908F0C Q37088000-3EE3F378-08AB-40A4-B103-48CEADE19AEF Q37121488-B67D184F-583A-4BB7-8410-A0B1211F6B7D Q37271875-48B64B73-8E2D-4D5C-A060-83E12036945A Q37599845-1415A2B5-B67A-4DF3-AE4B-EE0CC292A72E Q37686168-1F3AB6D3-4DBD-4E03-BF84-54414572B2AF

P2860

Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer

http://www.wikidata.org/entity/Q36835186

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Inflammation-associated lysoph ...... ricted T cells in human cancer

@en

type

label

Inflammation-associated lysoph ...... ricted T cells in human cancer

@en

prefLabel

Inflammation-associated lysoph ...... ricted T cells in human cancer

@en

P1433

Q36835186-89277C55-36C0-4CBE-A8A9-00D08F8E13D9

P1476

Q36835186-ABC3E131-23A8-4F7F-A88A-84E7106B4059

P2093

Q36835186-1704E1EC-4FBD-48B5-B505-9E06DAC2AA99

Q36835186-18CC73D2-874C-4C83-85CF-61DF7E94C0FA

Q36835186-3F2A66C9-427F-44A4-A4C9-930CDC1A18DC

Q36835186-416ABD8F-6D42-42E8-82B8-F531E3A6DC48

Q36835186-5F018D15-E5B9-4213-AFAB-2181C1BF98C2

Q36835186-84B5DEBF-AA20-441D-BBD7-4B3C7CA585F2

Q36835186-D345FF55-F5F1-42BF-84C8-C9BCBA8D97E2

Q36835186-D6AD795B-5585-44D2-940C-4626DBCBF354

Q36835186-DA77C310-56BC-4DAF-AE72-FBED8D7C5B63

Q36835186-E1EC959E-5D3D-403B-8EC6-A59CF6DE2A92

P2860

Q36835186-0B1C2D38-C63B-483D-B323-C591B110B684

Q36835186-0DC5C098-4194-4556-8F50-BB787EAED3E0

Q36835186-0ED5E43D-070E-4DB7-B17D-F53E03D5E5B5

Q36835186-1165D943-5E54-4844-9E6D-01E0E652ECF8

Q36835186-265CE658-C7F9-4FED-BC73-3147EF8FA9C7

Q36835186-29CBE706-7055-48B0-8941-F9EBF083361B

Q36835186-2F6029B4-C39C-4E2D-B04D-46DA53EBFE74

Q36835186-31F5A937-E9ED-413F-A8F3-4260B7AA5069

Q36835186-389C13B2-ECE8-41F8-809C-08A90C01C148

Q36835186-3D923546-7917-408A-9016-3F70C2293A6F

P304

Q36835186-15F42E0C-B4D7-4F50-8162-15B5FD432611

P31

Q36835186-5E4AE636-6779-4B89-990E-1A5C43252C17

P356

Q36835186-9A6D7EE9-75DE-4974-AE55-81593CE3F01C

P407

Q36835186-44BE3258-839E-45ED-BE9C-B09ECC031910

P433

Q36835186-F4832839-2D43-4BEF-9D27-29D0551A179E

P478

Q36835186-56B15DB5-A34A-4D71-9870-238D82B939C6

P577

Q36835186-1F76E086-D62E-4F62-83F5-0A5EDA23E315

P5875

Q36835186-3C38DCD1-C36C-43CE-A39F-4C890CFF3A52

P698

Q36835186-23B6F4B0-DF4F-44D7-8DB3-7BB048360680

P921

Q36835186-8C0C2CE6-CA96-4E6E-A649-79442831DF9A

P932

Q36835186-73129C18-9D60-4CFD-81CC-7EBBA74EDD33

P356

BLOOD-2008-04-149831

P1433

P1476

Inflammation-associated lysoph ...... ricted T cells in human cancer

@en

P2093

Amitabha Mazumder

http://www.w3.org/2001/XMLSchema#string

David H Chang

http://www.w3.org/2001/XMLSchema#string

David H Vesole

http://www.w3.org/2001/XMLSchema#string

Govind Ragupathi

http://www.w3.org/2001/XMLSchema#string

Haiteng Deng

http://www.w3.org/2001/XMLSchema#string

Joseph Krasovsky

http://www.w3.org/2001/XMLSchema#string

Madhav V Dhodapkar

http://www.w3.org/2001/XMLSchema#string

Phillip Matthews

http://www.w3.org/2001/XMLSchema#string

Radek Spisek

http://www.w3.org/2001/XMLSchema#string

Sundar Jagannath

http://www.w3.org/2001/XMLSchema#string

P2860

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

IL-13 effector functions

The emerging role of lysophosphatidic acid in cancer

CD1d ligands: the good, the bad, and the ugly

Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.

The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS.

Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.

Analysis of nonvolatile lipids by mass spectrometry.

Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

P304

1308-1316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-04-149831

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5320790

http://www.w3.org/2001/XMLSchema#string

P698

18535199

http://www.w3.org/2001/XMLSchema#string

P921

P932

2515141

http://www.w3.org/2001/XMLSchema#string